SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pan Chen, Margaret R. DeWitt, Julia Bornhorst, Felix A. Soares, Somshuvra Mukhopadhyay, Aaron B. Bowman, Michael Aschner, Age- and manganese-dependent modulation of dopaminergic phenotypes in a C. elegans DJ-1 genetic model of Parkinson's disease, Metallomics, 2015, 7, 2, 289

    CrossRef

  2. 2
    Michaela E. Johnson, Larisa Bobrovskaya, An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions, NeuroToxicology, 2015, 46, 101

    CrossRef

  3. 3
    Jorge Landgrave-Gómez, Octavio Mercado-Gómez, Rosalinda Guevara-Guzmán, Epigenetic mechanisms in neurological and neurodegenerative diseases, Frontiers in Cellular Neuroscience, 2015, 9,

    CrossRef

  4. 4
    Hao Wu, Quan Chen, Hypoxia Activation of Mitophagy and Its Role in Disease Pathogenesis, Antioxidants & Redox Signaling, 2015, 150210140142008

    CrossRef

  5. 5
    Jaclyn Nicole Le Grand, Laura Gonzalez-Cano, Maria Angeliki Pavlou, Jens C. Schwamborn, Neural stem cells in Parkinson’s disease: a role for neurogenesis defects in onset and progression, Cellular and Molecular Life Sciences, 2015, 72, 4, 773

    CrossRef

  6. 6
    Yong Ren, Houbo Jiang, Zhixing Hu, Kevin Fan, Jun Wang, Stephen Janoschka, Xiaomin Wang, Shaoyu Ge, Jian Feng, Parkin Mutations Reduce the Complexity of Neuronal Processes in iPSC-Derived Human Neurons, STEM CELLS, 2015, 33, 1
  7. 7
    Aline Verstraeten, Jessie Theuns, Christine Van Broeckhoven, Progress in unraveling the genetic etiology of Parkinson disease in a genomic era, Trends in Genetics, 2015, 31, 3, 140

    CrossRef

  8. 8
    Andreas Puschmann, Zbigniew K. Wszolek, Movement Disorders, 2015,

    CrossRef

  9. 9
    Jianfeng Xiao, Satya Vemula, Zhenyu Yue, Movement Disorders, 2015,

    CrossRef

  10. 10
    Debkanya Datta, Kwang-Soo Kim, Movement Disorders, 2015,

    CrossRef

  11. 11
    Simona Petrucci, Giuseppe Arena, Enza M. Valente, Movement Disorders, 2015,

    CrossRef

  12. You have free access to this content12
    Una-Marie Sheerin, Henry Houlden, Nicholas W. Wood, Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician, Movement Disorders Clinical Practice, 2014, 1, 1
  13. 13
    Eun-Jin Bae, Cheolsoon Lee, He-Jin Lee, Seokjoong Kim, Seung-Jae Lee, ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells, Experimental Neurobiology, 2014, 23, 4, 365

    CrossRef

  14. 14
    Neena Singh, Swati Haldar, Ajai K. Tripathi, Katharine Horback, Joseph Wong, Deepak Sharma, Amber Beserra, Srinivas Suda, Charumathi Anbalagan, Som Dev, Chinmay K. Mukhopadhyay, Ajay Singh, Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities, Antioxidants & Redox Signaling, 2014, 20, 8, 1324

    CrossRef

  15. 15
    A Markham, R Bains, P Franklin, M Spedding, Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: How important is BDNF?, British Journal of Pharmacology, 2014, 171, 8
  16. 16
    Lasse Pihlstrøm, Aina Rengmark, Kari Anne Bjørnarå, Mathias Toft, Effective Variant Detection by Targeted Deep Sequencing of DNA Pools: An Example from Parkinson's Disease, Annals of Human Genetics, 2014, 78, 3
  17. 17
    Izabella D. Greene, Francis Mastaglia, Bruno P. Meloni, Kristin A. West, Joanne Chieng, Chris J. Mitchell, Wei-Ping Gai, Sherif Boulos, Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation, Journal of Neuroscience Research, 2014, 92, 4
  18. 18
    Wei Lu, Senthilkumar S. Karuppagounder, Danielle A. Springer, Michele D. Allen, Lixin Zheng, Brittany Chao, Yan Zhang, Valina L. Dawson, Ted M. Dawson, Michael Lenardo, Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson’s-like movement disorder, Nature Communications, 2014, 5, 4930

    CrossRef

  19. 19
    Nancy Monroy-Jaramillo, Jorge Luis Guerrero-Camacho, Mayela Rodríguez-Violante, Marie-Catherine Boll-Woehrlen, Petra Yescas-Gómez, María Elisa Alonso-Vilatela, Marisol López-López, Genetic mutations in early-onset Parkinson's disease Mexican patients: Molecular testing implications, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014, 165, 3
  20. 20
    Hao Deng, Lamei Yuan, Genetic variants and animal models in SNCA and Parkinson disease, Ageing Research Reviews, 2014, 15, 161

    CrossRef

  21. 21
    Nicoleta Moisoi, Valentina Fedele, Jennifer Edwards, L. Miguel Martins, Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress, Neuropharmacology, 2014, 77, 350

    CrossRef

  22. 22
    Zhiping Hu, Binbin Yang, Xiaoye Mo, Han Xiao, Mechanism and Regulation of Autophagy and Its Role in Neuronal Diseases, Molecular Neurobiology, 2014,

    CrossRef

  23. 23
    Lucía F. Cardo, Eliecer Coto, René Ribacoba, Manuel Menéndez, Germán Moris, Esther Suárez, Victoria Alvarez, MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy Subjects, Journal of Molecular Neuroscience, 2014, 54, 4, 830

    CrossRef

  24. 24
    Edith Sturm, Nadia Stefanova, Multiple System Atrophy: Genetic or Epigenetic?, Experimental Neurobiology, 2014, 23, 4, 277

    CrossRef

  25. 25
    Konstanze F. Winklhofer, Parkin and mitochondrial quality control: toward assembling the puzzle, Trends in Cell Biology, 2014, 24, 6, 332

    CrossRef

  26. 26
    A. L. Schwarzman, S. V. Sarantseva, Pathology of synapses in neurological diseases, Biology Bulletin Reviews, 2014, 4, 6, 515

    CrossRef

  27. 27
    Ryan D. Mills, Terrence D. Mulhern, Fei Liu, Janetta G. Culvenor, Heung-Chin Cheng, Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2), Human Mutation, 2014, 35, 4
  28. 28
    Steven Lubbe, Huw R. Morris, Recent advances in Parkinson’s disease genetics, Journal of Neurology, 2014, 261, 2, 259

    CrossRef

  29. 29
    Sabrina Büttner, Filomena Broeskamp, Cornelia Sommer, Maria Markaki, Lukas Habernig, Ali Alavian-Ghavanini, Didac Carmona-Gutierrez, Tobias Eisenberg, Eva Michael, Guido Kroemer, Nektarios Tavernarakis, Stephan J Sigrist, Frank Madeo, Spermidine protects against α-synuclein neurotoxicity, Cell Cycle, 2014, 13, 24, 3903

    CrossRef

  30. 30
    Fabio Coppedè, The potential of epigenetic therapies in neurodegenerative diseases, Frontiers in Genetics, 2014, 5,

    CrossRef

  31. 31
    Parveen Salahuddin, Gulam Rabbani, Rizwan Khan, The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach, Cellular and Molecular Biology Letters, 2014, 19, 3

    CrossRef

  32. 32
    Jinyoung Lee, Jennifer L. Freeman, Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: A mini-review, NeuroToxicology, 2014, 43, 57

    CrossRef

  33. 33
    C. George Priya Doss, Chiranjib Chakraborty, Vaishnavi Narayan, D. Thirumal Kumar, 2014,

    CrossRef

  34. 34
    Fabio Coppedè, Epigenetics in Psychiatry, 2014,

    CrossRef

  35. 35
    Donald E. Spratt, R Julio Martinez-Torres, Yeong J. Noh, Pascal Mercier, Noah Manczyk, Kathryn R. Barber, Jacob D. Aguirre, Lynn Burchell, Andrew Purkiss, Helen Walden, Gary S. Shaw, A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease, Nature Communications, 2013, 4,

    CrossRef

  36. 36
    Shin-ichiro Kubo, Taku Hatano, Masashi Takanashi, Nobutaka Hattori, Can parkin be a target for future treatment of Parkinson's disease?, Expert Opinion on Therapeutic Targets, 2013, 17, 10, 1133

    CrossRef

  37. 37
    Francesca Sironi, Paola Primignani, Sara Ricca, Sara Tunesi, Michela Zini, Silvana Tesei, Roberto Cilia, Gianni Pezzoli, Manuela Seia, Stefano Goldwurm, DJ1 analysis in a large cohort of Italian early onset Parkinson Disease patients, Neuroscience Letters, 2013, 557, 165

    CrossRef

  38. 38
    Karla Cristina Vasconcelos Moura, Mário Campos Junior, Ana Lúcia Zuma de Rosso, Denise Hack Nicaretta, João Santos Pereira, Delson José Silva, Flávia Lima dos Santos, Fabíola da Costa Rodrigues, Cíntia Barros Santos-Rebouças, Márcia Mattos Gonçalves Pimentel, Genetic Analysis ofPARK2andPINK1Genes in Brazilian Patients with Early-Onset Parkinson's Disease, Disease Markers, 2013, 35, 181

    CrossRef

  39. 39
    Claudia Funke, Susanne A. Schneider, Daniela Berg, Douglas B. Kell, Genetics and iron in the systems biology of Parkinson’s disease and some related disorders, Neurochemistry International, 2013, 62, 5, 637

    CrossRef

  40. 40
    Liyong Wang, Karen Nuytemans, Guney Bademci, Cherylyn Jauregui, Eden R. Martin, William K. Scott, Jeffery M. Vance, Stephan Zuchner, High-Resolution Survey in Familial Parkinson Disease Genes Reveals Multiple Independent Copy Number Variation Events in PARK2, Human Mutation, 2013, 34, 8
  41. 41
    Justine D. Miller, Yosif M. Ganat, Sarah Kishinevsky, Robert L. Bowman, Becky Liu, Edmund Y. Tu, Pankaj K. Mandal, Elsa Vera, Jae-won Shim, Sonja Kriks, Tony Taldone, Noemi Fusaki, Mark J. Tomishima, Dimitri Krainc, Teresa A. Milner, Derrick J. Rossi, Lorenz Studer, Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging, Cell Stem Cell, 2013, 13, 6, 691

    CrossRef

  42. 42
    Dariusz Koziorowski, Dorota Hoffman-Zacharska, Jarosław Sławek, Zygmunt Jamrozik, Piotr Janik, Anna Potulska-Chromik, Anna Roszmann, Renata Tataj, Jerzy Bal, Andrzej Friedman, Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients, Neurologia i Neurochirurgia Polska, 2013, 47, 4, 319

    CrossRef

  43. 43
    Xinmin Liu, Rong Cheng, Xin Ye, Miguel Verbitsky, Sergey Kisselev, Helen Mejia-Santana, Elan D. Louis, Lucien J. Cote, Howard F. Andrews, Cheryl H. Waters, Blair Ford, Stanley Fahn, Karen Marder, Joseph H. Lee, Lorraine N. Clark, Increased rate of sporadic and recurrent rare genic copy number variants in Parkinson's disease among Ashkenazi Jews, Molecular Genetics & Genomic Medicine, 2013, 1, 3
  44. 44
    Leonardo Bonilla-Ramirez, Marlene Jimenez-Del-Rio, Carlos Velez-Pardo, Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: Implication in autosomal recessive juvenile Parkinsonism, Gene, 2013, 512, 2, 355

    CrossRef

  45. 45
    Margaret R. DeWitt, Pan Chen, Michael Aschner, Manganese efflux in Parkinsonism: Insights from newly characterized SLC30A10 mutations, Biochemical and Biophysical Research Communications, 2013, 432, 1, 1

    CrossRef

  46. 46
    Dong Wang, Chih-Chiang Chan, Smita Cherry, P. Robin Hiesinger, Membrane trafficking in neuronal maintenance and degeneration, Cellular and Molecular Life Sciences, 2013, 70, 16, 2919

    CrossRef

  47. 47
    Rosa L.A. de Vries, Serge Przedborski, Mitophagy and Parkinson's disease: Be eaten to stay healthy, Molecular and Cellular Neuroscience, 2013, 55, 37

    CrossRef

  48. 48
    Shannon Stefl, Hafumi Nishi, Marharyta Petukh, Anna R. Panchenko, Emil Alexov, Molecular Mechanisms of Disease-Causing Missense Mutations, Journal of Molecular Biology, 2013, 425, 21, 3919

    CrossRef

  49. 49
    Peizhong Mao, Charles Meshul, Philippe Thuillier, P. Reddy, Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease, Pharmaceuticals, 2013, 6, 1, 108

    CrossRef

  50. 50
    Jia Nee Foo, Jianjun Liu, Eng-King Tan, Next-generation sequencing diagnostics for neurological diseases/disorders: from a clinical perspective, Human Genetics, 2013, 132, 7, 721

    CrossRef

  51. 51
    Mariaelena Repici, Kornelis R. Straatman, Nadia Balduccio, Francisco J. Enguita, Tiago F. Outeiro, Flaviano Giorgini, Parkinson’s disease-associated mutations in DJ-1 modulate its dimerization in living cells, Journal of Molecular Medicine, 2013, 91, 5, 599

    CrossRef

  52. 52
    Sorabh Sharma, Kushal Kumar, Rahul Deshmukh, Pyare Lal Sharma, Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders, European Journal of Pharmacology, 2013, 714, 1-3, 486

    CrossRef

  53. 53
    M. Lazarou, D. P. Narendra, S. M. Jin, E. Tekle, S. Banerjee, R. J. Youle, PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding, The Journal of Cell Biology, 2013, 200, 2, 163

    CrossRef

  54. 54
    D. P. Narendra, C. Wang, R. J. Youle, J. E. Walker, PINK1 rendered temperature sensitive by disease-associated and engineered mutations, Human Molecular Genetics, 2013, 22, 13, 2572

    CrossRef

  55. 55
    Lucía F. Cardo, Eliecer Coto, Lorena Mena, Renée Ribacoba, Germán Moris, Manuel Menéndez, Victoria Alvarez, Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls, Journal of Neurology, 2013, 260, 5, 1420

    CrossRef

  56. 56
    Erika Guerrero, P. Vasudevaraju, Muralidhar L. Hegde, G. B. Britton, K. S. Rao, Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson’s Disease, Molecular Neurobiology, 2013, 47, 2, 525

    CrossRef

  57. 57
    Natalie A. Twine, Caroline Janitz, Marc R. Wilkins, Michael Janitz, Sequencing of hippocampal and cerebellar transcriptomes provides new insights into the complexity of gene regulation in the human brain, Neuroscience Letters, 2013, 541, 263

    CrossRef

  58. 58
    David M. Duda, Jennifer L. Olszewski, Jonathan P. Schuermann, Igor Kurinov, Darcie J. Miller, Amanda Nourse, Arno F. Alpi, Brenda A. Schulman, Structure of HHARI, a RING-IBR-RING Ubiquitin Ligase: Autoinhibition of an Ariadne-Family E3 and Insights into Ligation Mechanism, Structure, 2013, 21, 6, 1030

    CrossRef

  59. 59
    Hongyu Diao, Xinxing Li, Sheng Hu, The identification of dysfunctional crosstalk of pathways in Parkinson disease, Gene, 2013, 515, 1, 159

    CrossRef

  60. 60
    Thomas A. Peterson, Emily Doughty, Maricel G. Kann, Towards Precision Medicine: Advances in Computational Approaches for the Analysis of Human Variants, Journal of Molecular Biology, 2013, 425, 21, 4047

    CrossRef

  61. 61
    Yiguan Wang, Xiaorong Yang, Association of Catechol-O-Methyltransferase Polymorphism (Val108/158Met) With Parkinson's Disease: A Meta-Analysis, Journal of Motor Behavior, 2012, 44, 5, 365

    CrossRef

  62. 62
    Yishu Zhou, Xiaoguang Luo, Fengrui Li, Xiaofei Tian, Lanhui Zhu, Yichun Yang, Yan Ren, Hao Pang, Association of Parkinson’s disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population, Journal of Clinical Neuroscience, 2012, 19, 7, 1011

    CrossRef

  63. 63
    Nobutaka Hattori, Autosomal dominant Parkinsonism: its etiologies and differential diagnoses, Parkinsonism & Related Disorders, 2012, 18, S1

    CrossRef

  64. 64
    Reika Iwakawa, Hirokazu Okayama, Takashi Kohno, Aiko Sato-Otsubo, Seishi Ogawa, Jun Yokota, Contribution of germline mutations to PARK2 gene inactivation in lung adenocarcinoma, Genes, Chromosomes and Cancer, 2012, 51, 5
  65. 65
    Justin P. Rubio, Simon Topp, Liling Warren, Pamela L. St. Jean, Daniel Wegmann, Darren Kessner, John Novembre, Judong Shen, Dana Fraser, Jennifer Aponte, Keith Nangle, Lon R. Cardon, Margaret G. Ehm, Stephanie L. Chissoe, John C. Whittaker, Matthew R. Nelson, Vincent E. Mooser, Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe, Human Mutation, 2012, 33, 7
  66. 66
    Elzbieta Janda, Ciro Isidoro, Cristina Carresi, Vincenzo Mollace, Defective Autophagy in Parkinson’s Disease: Role of Oxidative Stress, Molecular Neurobiology, 2012, 46, 3, 639

    CrossRef

  67. You have free access to this content67
    Christina M. Lill, Lars Bertram, Developing the “next generation” of genetic association databases for complex diseases, Human Mutation, 2012, 33, 9
  68. 68
    Bram Meeus, Aline Verstraeten, David Crosiers, Sebastiaan Engelborghs, Marleen Van den Broeck, Maria Mattheijssens, Karin Peeters, Ellen Corsmit, Ellen Elinck, Barbara Pickut, Rik Vandenberghe, Patrick Cras, Peter Paul De Deyn, Christine Van Broeckhoven, Jessie Theuns, DLB and PDD: a role for mutations in dementia and Parkinson disease genes?, Neurobiology of Aging, 2012, 33, 3, 629.e5

    CrossRef

  69. 69
    Renée Vancraenenbroeck, Evy Lobbestael, Stephen D. Weeks, Sergei V. Strelkov, Veerle Baekelandt, Jean-Marc Taymans, Marc De Maeyer, Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012, 1824, 3, 450

    CrossRef

  70. 70
    E. Lohmann, B. Dursun, S. Lesage, H. A. Hanagasi, G. Sevinc, A. Honore, B. Bilgic, H. Gürvit, O. Dogu, H. Kaleagası, G. Babacan, J. Yazici, N. Erginel-Unaltuna, A. Brice, M. Emre, Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population, European Journal of Neurology, 2012, 19, 5
  71. 71
    Fabio Coppedè, Genetics and Epigenetics of Parkinson's Disease, The Scientific World Journal, 2012, 2012, 1

    CrossRef

  72. 72
    Sang-Myung Cheon, Lilian Chan, Daniel Kam Yin Chan, Jae Woo Kim, Genetics of Parkinson’s Disease - A Clinical Perspective, Journal of Movement Disorders, 2012, 5, 2, 33

    CrossRef

  73. 73
    Jorge Luis Guerrero Camacho, Nancy Monroy Jaramillo, Petra Yescas Gómez, Mayela Rodríguez Violante, Catherine Boll Woehrlen, Ma. Elisa Alonso Vilatela, Marisol López López, High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease, Movement Disorders, 2012, 27, 8
  74. 74
    Marc Cruts, Jessie Theuns, Christine Van Broeckhoven, Locus-specific mutation databases for neurodegenerative brain diseases, Human Mutation, 2012, 33, 9
  75. 75
    Calvin Yu-Chian Chen, Mechanism of BAG1 repair on Parkinson’s disease-linked DJ1 mutation, Journal of Biomolecular Structure and Dynamics, 2012, 30, 1, 1

    CrossRef

  76. 76
    Nicole Exner, Anne Kathrin Lutz, Christian Haass, Konstanze F Winklhofer, Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences, The EMBO Journal, 2012, 31, 14
  77. 77
    Blake Byers, Hsiao-lu Lee, Renee Reijo Pera, Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells, Current Neurology and Neuroscience Reports, 2012, 12, 3, 237

    CrossRef

  78. 78
    Alfredo Ciccodicola, Maria Rosaria Ambrosio, Margherita Scarpato, Valerio Costa, Non-coding RNA in Neurodegeneration, Current Translational Geriatrics and Experimental Gerontology Reports, 2012, 1, 4, 219

    CrossRef

  79. 79
    Houbo Jiang, Yong Ren, Eunice Y. Yuen, Ping Zhong, Mahboobe Ghaedi, Zhixing Hu, Gissou Azabdaftari, Kazuhiro Nakaso, Zhen Yan, Jian Feng, Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells, Nature Communications, 2012, 3, 668

    CrossRef

  80. 80
    Anna Pilsl, Konstanze F. Winklhofer, Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson’s disease, Acta Neuropathologica, 2012, 123, 2, 173

    CrossRef

  81. 81
    C. Alves da Costa, F. Checler, Parkin: Much More than a Simple Ubiquitin Ligase, Neurodegenerative Diseases, 2012, 10, 1-4, 49

    CrossRef

  82. 82
    S Y Kim, M W Seong, B S Jeon, S Y Kim, H S Ko, J Y Kim, S S Park, Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease, Clinical Genetics, 2012, 82, 1
  83. 83
    Manabu Funayama, Hiroyo Yoshino, Yuanzhe Li, Hiromichi Kusaka, Hiroyuki Tomiyama, Nobutaka Hattori, Pseudo-heterozygous rearrangement mutation of parkin, Movement Disorders, 2012, 27, 4
  84. 84
    Beatriz Alvarez-Castelao, Carolina Muñoz, Isabel Sánchez, Marc Goethals, Joël Vandekerckhove, José G. Castaño, Reduced protein stability of human DJ-1/PARK7 L166P, linked to autosomal recessive Parkinson disease, is due to direct endoproteolytic cleavage by the proteasome, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012, 1823, 2, 524

    CrossRef

  85. 85
    Helen Walden, R. Julio Martinez-Torres, Regulation of Parkin E3 ubiquitin ligase activity, Cellular and Molecular Life Sciences, 2012, 69, 18, 3053

    CrossRef

  86. 86
    Suzanne Lesage, Alexis Brice, Role of Mendelian genes in “sporadic” Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S66

    CrossRef

  87. 87
    Vivianna M. Van Deerlin, The genetics and neuropathology of neurodegenerative disorders: perspectives and implications for research and clinical practice, Acta Neuropathologica, 2012, 124, 3, 297

    CrossRef

  88. 88
    Henry Houlden, Andrew B. Singleton, The genetics and neuropathology of Parkinson’s disease, Acta Neuropathologica, 2012, 124, 3, 325

    CrossRef

  89. 89
    Arati A. Inamdar, Anathbandhu Chaudhuri, Janis O’Donnell, The Protective Effect of Minocycline in a Paraquat-Induced Parkinson's Disease Model inDrosophilais Modified in Altered Genetic Backgrounds, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  90. 90
    Kurt Jellinger, The role of α-synuclein in neurodegeneration — An update, Translational Neuroscience, 2012, 3, 2

    CrossRef

  91. 91
    Gaynor A. Smith, Ole Isacson, Stephen B. Dunnett, The search for genetic mouse models of prodromal Parkinson's disease, Experimental Neurology, 2012, 237, 2, 267

    CrossRef

  92. 92
    P. Riederer, J. Sian-Hülsmann, The significance of neuronal lateralisation in Parkinson’s disease, Journal of Neural Transmission, 2012, 119, 8, 953

    CrossRef

  93. 93
    M. Vishwanathan Padmaja, Meenakshi Jayaraman, Avathvadi Venkatesan Srinivasan, C.R. Srikumari Srisailapathy, Arabandi Ramesh, The SNCA (A53T, A30P, E46K) and LRRK2 (G2019S) mutations are rare cause of Parkinson's disease in South Indian patients, Parkinsonism & Related Disorders, 2012, 18, 6, 801

    CrossRef

  94. 94
    Jesse R. McLean, Penelope J. Hallett, Oliver Cooper, Michael Stanley, Ole Isacson, Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression, Molecular and Cellular Neuroscience, 2012, 49, 2, 230

    CrossRef

  95. 95
    Andrew Sauerbeck, Randy Hunter, Guoying Bing, Patrick G. Sullivan, Traumatic brain injury and trichloroethylene exposure interact and produce functional, histological, and mitochondrial deficits, Experimental Neurology, 2012, 234, 1, 85

    CrossRef

  96. 96
    Jean-Christophe Rochet, Bruce A. Hay, Ming Guo, Molecular Biology of Neurodegenerative Diseases, 2012,

    CrossRef

  97. 97
    Christina M. Lill, Rudolph E. Tanzi, Lars Bertram, Basic Neurochemistry, 2012,

    CrossRef

  98. 98
    Peter Elfferich, Marja C. Verleun-Mooijman, J. Anneke Maat-Kievit, Bart P. C. van de Warrenburg, Wilson F. Abdo, Sylvia A. Eshuis, Klaus L. Leenders, Ad Hovestadt, Jan C. M. Zijlmans, Jan-Pieter M. Stroy, John C. van Swieten, Agnita J. W. Boon, Klaartje van Engelen, Corien C. Verschuuren-Bemelmans, Saskia A. J. Lesnik-Oberstein, Cristina Tassorelli, Leonardo Lopiano, Vincenzo Bonifati, Dennis Dooijes, Rick van Minkelen, Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations, neurogenetics, 2011, 12, 4, 263

    CrossRef

  99. 99
    Andrea Haworth, Lars Bertram, Paola Carrera, Joanna L. Elson, Corey D. Braastad, Diane W. Cox, Marc Cruts, Johann T. den Dunnen, Matthew J. Farrer, John K. Fink, Sherifa A. Hamed, Henry Houlden, Dennis R. Johnson, Karen Nuytemans, Francesc Palau, Dipa L. Raja Rayan, Peter N. Robinson, Antonio Salas, Birgitt Schüle, Mary G. Sweeney, Michael O. Woods, Jorge Amigo, Richard G. H. Cotton, Maria-Jesus Sobrido, Call for participation in the neurogenetics consortium within the Human Variome Project, neurogenetics, 2011, 12, 3, 169

    CrossRef

  100. 100
    Doaa I. Hashad, Abla A. Abou-Zeid, Ghada A. Achmawy, Horeya M.O. Saad Allah, Marwa A. Saad, G2019S Mutation of the Leucine-Rich Repeat Kinase 2 Gene in a Cohort of Egyptian Patients with Parkinson's Disease, Genetic Testing and Molecular Biomarkers, 2011, 15, 12, 861

    CrossRef

  101. 101
    Hui-Ming Gao, Jau-Shyong Hong, Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease, Progress in Neurobiology, 2011, 94, 1, 1

    CrossRef

  102. 102
    Sylvia Stemberger, Sonja W. Scholz, Andrew B. Singleton, Gregor K. Wenning, Genetic players in multiple system atrophy: unfolding the nature of the beast, Neurobiology of Aging, 2011, 32, 10, 1924.e5

    CrossRef

  103. 103
    Xinmin Liu, Rong Cheng, Miguel Verbitsky, Sergey Kisselev, Andrew Browne, Helen Mejia-Sanatana, Elan D Louis, Lucien J Cote, Howard Andrews, Cheryl Waters, Blair Ford, Steven Frucht, Stanley Fahn, Karen Marder, Lorraine N Clark, Joseph H Lee, Genome-Wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population, BMC Medical Genetics, 2011, 12, 1, 104

    CrossRef

  104. 104
    Janusz Lipski, Robert Nistico, Nicola Berretta, Ezia Guatteo, Giorgio Bernardi, Nicola B. Mercuri, l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?, Progress in Neurobiology, 2011, 94, 4, 389

    CrossRef

  105. 105
    Zhifeng Qi, Weiwei Yang, Yujun Liu, Tao Cui, Hua Gao, Chunli Duan, Lingling Lu, Chunli Zhao, Huanying Zhao, Hui Yang, Loss of PINK1 function decreases PP2A activity and promotes autophagy in dopaminergic cells and a murine model, Neurochemistry International, 2011, 59, 5, 572

    CrossRef

  106. 106
    Maria Trinidad Herrero, Javier Pagonabarraga, Gurutz Linazasoro, Neuroprotective Role of Dopamine Agonists, The Neurologist, 2011, 17, S54

    CrossRef

  107. 107
    David Crosiers, Jessie Theuns, Patrick Cras, Christine Van Broeckhoven, Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes, Journal of Chemical Neuroanatomy, 2011, 42, 2, 131

    CrossRef

  108. 108
    Josef Finsterer, Parkinson's syndrome and Parkinson's disease in mitochondrial disorders, Movement Disorders, 2011, 26, 5
  109. 109
    Marie Therese Armentero, Annalisa Pinna, Sergi Ferré, José Luis Lanciego, Christa E. Müller, Rafael Franco, Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease, Pharmacology & Therapeutics, 2011, 132, 3, 280

    CrossRef

  110. 110
    Paolo Aridon, Fabiana Geraci, Giuseppina Turturici, Marco D’Amelio, Giovanni Savettieri, Gabriella Sconzo, Protective Role of Heat Shock Proteins in Parkinson’s Disease, Neurodegenerative Diseases, 2011, 8, 4, 155

    CrossRef

  111. 111
    Ian Martin, Valina L. Dawson, Ted M. Dawson, Recent Advances in the Genetics of Parkinson's Disease, Annual Review of Genomics and Human Genetics, 2011, 12, 1, 301

    CrossRef

  112. 112
    Azad Kumar, Mark R. Cookson, Role of LRRK2 kinase dysfunction in Parkinson disease, Expert Reviews in Molecular Medicine, 2011, 13,

    CrossRef

  113. 113
    Giorgio Vivacqua, Arianna Casini, Rosa Vaccaro, Ebe Parisi Salvi, Livia Pasquali, Francesco Fornai, Shun Yu, Loredana D’Este, Spinal cord and parkinsonism: Neuromorphological evidences in humans and experimental studies, Journal of Chemical Neuroanatomy, 2011, 42, 4, 327

    CrossRef

  114. 114
    George D Mellick, Peter A Silburn, Greg T Sutherland, Gerhard A Siebert, Exploiting the potential of molecular profiling in Parkinson’s disease: current practice and future probabilities, Expert Review of Molecular Diagnostics, 2010, 10, 8, 1035

    CrossRef

  115. 115
    SHIN-ICHI MURAMATSU, SAYAKA ASARI, KEN-ICHI FUJIMOTO, KEIYA OZAWA, IMAHARU NAKANO, GENE THERAPY FOR PARKINSON'S DISEASE: STRATEGIES FOR THE LOCAL PRODUCTION OF DOPAMINE, Gene Therapy and Regulation, 2010, 05, 01, 57

    CrossRef

  116. 116
    Aiwu Cheng, Yan Hou, Mark P Mattson, Mitochondria and neuroplasticity, ASN NEURO, 2010, 2, 5, 243

    CrossRef

  117. 117
    Susana Gonçalves, Hugo Vicente Miranda, Tiago F. Outeiro, Novel Molecular Therapeutics in Parkinson's Disease,